Store launching soon — browse the catalog and join the waitlist to be notified at launch.
✦USPS Priority Mail1–3 day delivery across the U.S.Free on orders over $200
Store launching soon — browse the catalog and join the waitlist to be notified at launch.
Your cart is empty
Recovery Blend
Also known as Cartalax 10mg + BPC-157 5mg + TB-500 5mg
Wolverine+ is a research blend supplying cartalax, BPC-157, and TB-500 in a single vial.
🚀 Launching soon — join the waitlist to be notified when this product is available.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Wolverine+ is a research blend supplying cartalax, BPC-157, and TB-500 in a single vial.
Each component is separately studied in tissue-repair research; the combination itself has no published literature.
Third-party tested for purity, ID, quantity.
Wolverine+ combines a short peptide bioregulator associated with cartilage models (cartalax, Ala-Glu-Asp-Pro) with two peptides that recur in tissue-repair research. BPC-157 is a synthetic fragment of a gastric protein studied for angiogenic and inflammatory signaling. TB-500 corresponds to an active region of thymosin beta-4, studied for actin binding and cell migration.
The combination is a formulation choice. References below are drawn from the component literature.
The components entered research independently: BPC-157 through gastric-protein fragment work, thymosin beta-4 through actin-sequestering protein research, and cartalax through the short-peptide bioregulator programme.
The blend has no separate development history and is a supplier formulation.
Research relevant to Wolverine+ is the sum of its components: angiogenic and inflammatory signaling, actin-binding and cell migration, and short-peptide regulation in connective-tissue models. No study has evaluated this specific three-component combination.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains the labeled quantity of Wolverine+. Independent third-party analysis verifies purity, identity, and net content per batch.
The unit contains only the research compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC. J Physiol Paris 87(5):313–327.
PubMedGastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res 21(6):976–983.
PubMedThymosin beta4 accelerates wound healing. J Invest Dermatol 113(3):364–368.
PubMedThymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432(7016):466–472.
PubMedGene expression in human mesenchymal stem cell aging cultures: modulation by short peptides.
PubMedRelated
Pentadecapeptide studied for angiogenesis signaling, tissue repair pathways, and cellular regeneration research
From$50.00
$60.00
Small molecule studied for metabolic regulation, NAD pathways, and cellular energy signaling
From$40.00
Dual peptide complex studied for actin signaling, tissue regeneration pathways, and recovery system research
From$0.00
Oral peptide format studied for systemic repair signaling and gastrointestinal pathway research
$140.00
